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Abstract
The objectives were to analyze one-year sur-
vival and mortality predictors in patients with 
fracture of the proximal femur (low/moderate 
trauma). A prospective cohort was formed by in-
viting all patients hospitalized in the Orthopedic 
Ward of the second largest hospital in Portugal 
(May 2008-April 2009). Survival was assessed at 
3, 6, 9, and 12 months after fracture and related 
to demographic factors, lifestyle, and clinical 
history, as well as to data from medical records 
(fracture type, surgery date, surgical treatment, 
and preoperative risk). Of the 340 patients hos-
pitalized, 252 were included (78.9% women). 
Mortality at 3, 6, 9, and 12 months was 21.2%, 
25%, 28.8%, and 34.6% for men and 7.8%, 13.5%, 
19.2%, and 21.4% for women, respectively. Pre-
dictors of death were male gender (HR = 2.54; 
95%CI: 1.40-4.58), ASA score III/IV vs. I/II (HR = 
1.95; 95%CI: 1.10-3.47), age (HR = 1.06; 95%CI: 
1.03-1.10), and delay in days to surgery (HR = 
1.07; 95%CI: 1.03-1.12). Factors related to death 
were mainly related to patients’ characteristics 
at admission.
Hip Fractures; Survival; Mortality
Resumo
Os objetivos foram analisar a sobrevivência após 
um ano e os fatores associados para doentes com 
fratura do fêmur proximal (baixo impacto). Foi 
constituída uma coorte com todos os doentes 
hospitalizados no serviço de ortopedia do segun-
do maior hospital de Portugal (maio de 2008 a 
abril de 2009). A sobrevivência foi avaliada aos 
3, 6, 9 e 12 meses após a fratura e relacionada 
com fatores demográficos, estilo de vida, história 
clínica e fatores médicos (tipo de fratura, data 
da cirurgia, tratamento e risco pré-operatório). 
Dos 340 doentes hospitalizados, 252 (78,9% mu-
lheres) foram incluídos. Mortalidade aos 3, 6, 9 
e 12 meses de seguimento foi 21,2%, 25%, 28,8%, 
34,6% para homens e 7,8%, 13,5%, 19,2%, 21,4% 
para mulheres. Os fatores associados com a 
mortalidade foram: sexo masculino (HR = 2,54; 
IC95%: 1,40-4,58), escore da American Society of 
Anesthesiologists mais elevado, III/IV vs. I/II (HR = 
1,95; IC95%: 1,10-3,47), idade (HR = 1,06; IC95%: 
1,03-1,10) e dias de atraso na cirurgia (HR = 
1,07; IC95%: 1,03-1,12). Fatores associados com 
a mortalidade estão na maioria relacionados 
com as características do doente na admissão.
Fraturas do Quadril; Sobrevivência; 
Mortalidade
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Introduction
Proximal femur fractures (PFF) create a public 
health burden due to their negative impact on 
the well-being of patients and families as well as 
on health systems, due to the need for care dur-
ing the acute and recovery phases 1,2. In Portugal, 
a retrospective study based on hospital admis-
sions reported 77,083 PFF from 2000 to 2008, or 
an average of 8,500 such fractures per year 3.
Most patients with PFF are older women 
(> 75 years) with underlying bone fragility and 
increased fracture risk 4. However, mortality is 
higher in men, although on average they are 
younger than women at the time of fracture 
5,6. Risk of death remains high in the first 3 to 6 
months after the fracture in both men and wom-
en, declining thereafter. However, mortality risk 
does not return to the same levels observed in the 
general population matched for age and gender 
but without PFF 7,8,9.
Early identification of patients at increased 
risk can help promote measures to reduce mor-
tality 10,11. Factors such as age, gender, mobility 
prior to the fracture, fracture type, time to sur-
gery, preexisting clinical conditions and their se-
verity, medical complications following the frac-
ture, and surgical treatment can influence the 
patient’s risk of death after a PFF 12,13,14,15.
As with incidence, survival after PFF dif-
fers between countries 9. Predictors of mortality 
have received little research attention in Portu-
gal. Available information on mortality after PFF 
in Portugal has relied on small patient samples 
from small hospitals 16,17,18.
We conducted a prospective cohort study 
with one year follow-up to analyze time to death 
in patients over 49 years of age with a PFF caused 
by low/moderate trauma and to determine the 
main predictors of mortality.
Methods
Participants
All patients admitted to the Orthopedic Ward of 
the São João Hospital (SJ Hospital) for treatment 
of an acute PFF caused by low/moderate trauma 
from May 1st, 2008, to April 30th, 2009, were in-
vited to participate. The local ethics committee 
approved the study on April 11th, 2005 (protocol 
n. 4/2005), and participants provided informed 
written consent in compliance with the Helsinki 
Declaration.
The SJ Hospital, the second largest hospi-
tal in Portugal, is located in Porto, a city of ap-
proximately 240,000 inhabitants (2009) located 
in Northwest Continental Portugal. Since all sus-
pected cases of PFF undergo x-ray to confirm the 
diagnosis, the registry of imaging tests (PACS – 
Picture Archiving and Communication System) 
was searched daily to identify patients treated at 
the emergency service for PFF. Hospitalization 
was confirmed by consulting the hospital data-
base or the nurses’ board in the Orthopedic Ward.
Data collection
A structured questionnaire adapted from the 
MEDOS Questionnaire 19 was used to record the 
patients’ age, gender, marital status, and living 
arrangement and daily activities (housekeeping, 
grocery shopping, childcare, walking) before the 
fracture, history of previous fractures, comorbid-
ities, and current medication. An open question 
for the description of the event that caused the 
fracture was also included. The same trained in-
terviewer applied all the questionnaires during 
hospitalization. Patients were defined as cogni-
tively impaired when they were unable to inform 
their age, date and place of birth, and place of 
residence. In such cases, whenever available the 
closest relative answered the questions (38% of 
respondents), otherwise the patient was exclud-
ed from the study.
During the study period 340 patients were 
treated for PFF at SJ Hospital, but the final sam-
ple consisted of 252 patients. Figure 1 shows the 
patient flow and exclusion criteria. Patients an-
swered the questionnaire four days after admis-
sion, on average.
To ensure accurate assessment of comor-
bidities, we analyzed hospital discharge records, 
which compile the following data on all dis-
charges: gender, age, date of admission and dis-
charge, cause of admission and main diagnosis 
(and up to 19 secondary causes and diagnoses) 
coded according to the International Classifica-
tion of Diseases, version 9, Clinical Modification 
(ICD9-CM), procedures during hospitalization, 
and transfers to and from other hospitals. Based 
on the hospital discharge registry, we selected all 
cases of PFF (ICD9-CM codes 820.x) during the 
study period.
Additional data were obtained from patients’ 
hospital records: type of fracture, surgical treat-
ment, and preoperative risk as defined by the 
American Society of Anesthesiologists, or ASA 
score, which classifies patients in five categories: 
I normal healthy patient; II patient with mild sys-
temic disease; III patient with severe systemic 
disease; IV patient with severe systemic disease 
that is a constant threat to life; and V moribund 
patient 20.
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Figure 1
Flow chart of participants’ selection (n = 252) and exclusion criteria of patients admitted to the Orthopedic Ward of São João 
Hospital, Portugal (May 1st, 2008, to April 30th, 2009).
Follow-up consisted of a short telephone 
interview with questions on mobility, place of 
residence after the fracture, independence in 
activities of daily living, and occurrence of new 
fractures. The questionnaire was applied at 3, 6, 
9, and 12 months after the index fracture by the 
same interviewer that applied the initial ques-
tionnaire in the hospital. Survival time was mea-
sured in days starting from the day of admission 
to day of death or end of study (for patients that 
were alive at the end of the study). For patients 
that died, the exact date of death was requested 
from the respondent (closest family member). 
Twenty-four patients could not be reached by 
telephone at any of the follow-up times, so sur-
vival time was determined by the last contact: 
in some cases the discharge date (n = 7), in oth-
ers the last appointment at any ward in the SJ 
Hospital (n = 16), or the last successful follow-up 
(n = 1).
Time (delay) to surgery was measured as the 
difference in calendar days between surgery date 
and admission date. For patients that suffered an 
additional fracture, survival time was measured 
from the second fracture.
Statistical analysis 
Summary statistics on participants’ characteris-
tics were computed (mean and standard devia-
tion or SD). Chi-square or Fisher’s exact test was 
used to assess associations between categorical 
variables, and independent sample t-test to com-
pare quantitative variables between two groups 
(after normality verification for groups less than 
30). Statistical significance was set at p < 0.05.
No adjustment was conducted for history of 
previous fractures.
Survival analysis was conducted using time 
from fracture either to death or to end of study 
for patients that survived. Univariate analysis 
was performed using Kaplan-Meier curves and 
log-rank test for the following independent vari-
ables: gender (female, male), marital status (wid-
owed, married, single/divorced), living arrange-
ment (with someone, alone, institution), daily 
activities before fracture (< 4 hours and ≥ 4 hours 
per day), number of comorbidities (0-1, 2-4, or 
≥ 5), type of surgery (osteosynthesis or arthro-
plasty), type of fracture [intracapsular (femoral 
neck) or extracapsular (trochanteric or subtro-
chanteric)], ASA score [low operative risk (ASA 
I-II) vs. high operative risk (ASA III-IV), with no 
patients classified as ASA V], and comorbidities 
(hypertension, heart disease, anemia, diabetes 
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mellitus, respiratory disease, cerebrovascular 
disease, renal disease, and dementia). Medica-
tion was analyzed using both a dichotomous 
variable (yes/no) as well as categories according 
to the Anatomical Therapeutic Chemical clas-
sification system 21.
Proportional hazard assumption was verified 
using plot option, and residual analysis was con-
ducted to assess the model’s quality. Interactions 
between variables were also tested.
The final multivariate Cox’s proportional haz-
ards model included all independent variables 
(described previously) with significant p-value 
after age adjustment (p < 0.05). The results are 
presented using hazards ratios (HR) and respec-
tive 95% confidence intervals (95%CI).
Results
Baseline
Table 1 shows the participants’ characteristics. 
Of the 252 patients included in the study, 78.9% 
were women, with mean age 80.3 years (SD 9.1) 
vs. 76.0 years (SD 11.5) in men (p = 0.015). Slightly 
more than half of the patients (52.8%) were over 
80 years old (range 50-105). All patients were ad-
mitted on the day of the fracture.
Only 7.5% of patients had no comorbidities. 
Fifty patients (19.8%) reported a history of previ-
ous fractures (hip, wrist, or spine); 48 were wom-
en. Six patients (one man) sustained a second 
fracture on the contralateral hip during the study 
period, one of which while hospitalized.
Table 1
Baseline characteristics of patients (n = 252) admitted to the Orthopedic Ward of São João Hospital, Portugal (May 1st, 2008, 
to April 30th, 2009).
Characteristics Women Men p-value
n % n %
Marital status
Widowed 114 57.3 13 24.5
Married 56 28.1 28 52.8
Single/Divorced 29 14.6 12 22.6 < 0.001
Living arrangement
With someone 132 66.3 37 69.8
Alone 51 25.6 13 24.5
Institution 16 8.0 3 5.7 0.815
Daily activities (hours per day)
≥ 4 63 31.7 22 41.5
< 4 136 68.3 31 58.5 0.178
Number of comorbidities
0-1 44 22.1 13 24.5
2-4 93 46.7 23 43.4
≥ 5 62 31.2 17 32.1 0.895
Comorbidities
Hypertension 111 55.8 20 37.7 0.019
Heart disease 64 32.2 16 30.2 0.784
Anemia 50 25.1 11 20.8 0.509
Diabetes mellitus 46 23.1 11 20.8 0.715
Respiratory disease 25 12.6 19 35.8 < 0.001
Thyroid disease 12 6.0 0 0.0 -
Cerebrovascular disease 26 13.1 7 13.2 0.974
Renal disease 13 6.5 5 9.4 0.367
Dementia 38 19.1 9 17.0 0.725
(continues)
Campos S et al.1532
Cad. Saúde Pública, Rio de Janeiro, 31(7):1528-1538, jul, 2015
Table 1 (continued)
Characteristics Women Men p-value
n % n %
Medication *
Yes 158 79.4 34 64.2
No 15 7.5 10 18.9 0.009
Type of medications used
Antihypertensive 84 42.2 20 37.7 0.713
Anxiolytics/Sedatives 63 31.7 8 15.1 0.021
Antithrombotic 44 22.1 14 26.4 0.393
Lipid modifying agents 38 19.1 4 7.5 0.054
Cardiac therapy 29 14.6 5 9.4 0.379
Antidepressants 27 13.6 2 3.8 0.054
Insulins and analogues 22 11.1 4 7.5 0.357
Blood glucose lowering drugs 16 8.1 4 7.5 0.619
Place of fall
Home 163 81.9 34 64.2
Outdoors 36 18.1 19 35.8 0.005
Type of fracture
Intracapsular 82 41.2 20 37.7
Extracapsular 117 58.8 33 62.3 0.647
Type of surgery **
Osteosynthesis 133 67.9 36 69.2
Arthroplasty 63 32.1 16 30.8 0.850
ASA score ***
I-II 102 52.6 24 47.1
III-IV 92 47.4 27 52.9 0.531
* Data not available for 35 patients; 
** Patients not submitted to surgery n = 4; 
*** Data not available for 3 patients with surgery.
Treatment was surgical in 98.4% of the pa-
tients. Mean time from admission to surgery was 
3.5 days (SD 4.4) in women versus 3.2 days (SD 
2.8) in men (p = 0.74). Approximately one- third 
(36.7%) of patients underwent surgery on the 
day of admission or the following day, 22% on 
the second day after admission, and 41% on sub-
sequent days. Time from admission to surgery 
in patients with ASA I or II was shorter (2.6 days; 
SD 2.8) than in patients with ASA III or IV (4.2 
days; SD 5.1) (p = 0.003). However, gender differ-
ences were identified: in patients with ASA III or 
IV, 33.7% of women underwent surgery on the 
day of admission or the following day compared 
to 7.4% of men (p = 0.007).
In patients on antithrombotic medication 
prior to the fracture, waiting time for surgery was 
4.8 days (SD 4.7) as opposed to other patients (3.1 
days; SD 3.9) (p = 0.012). Men on antithrombotic 
medication prior to the fracture waited longer 
for surgery (5.2 days; SD 3.4) when compared to 
women on the same medication (4.7 days; SD 
5.1) (p = 0.753), as well as compared to men not 
on prior antithrombotic medication (2.8 days; SD 
2.5) (p = 0.035).
Among patients on antithrombotic medica-
tion prior the fracture, 84.6% of men were ASA 
score III or IV, compared to 47.7% of women in 
the same ASA group (p = 0.018).
Mean length of hospital stay was similar in 
women and men, namely 14.9 days (SD 12.4) 
for women and 13.3 days (SD 12.3) for men 
(p = 0.421). Length of stay was greater for patients 
living alone prior to the fracture when compared 
to those living with someone else, i.e., 18.5 days 
(SD 15.7) and 13.4 days (SD 10.9) respectively 
(p = 0.021).
Follow-up
One year after the fracture, 59 patients had died 
(41 women and 18 men), 13 of whom died during 
hospitalization (8 women and 5 men). Mortal-
ity in men was higher at 3, 6, 9, and 12 months 
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follow-up, namely 21.2%, 25%, 28.8%, and 34.6%, 
compared to 7.8%, 13.5%, 19.2%, and 21.4% in 
women, respectively.
Survival analysis
Overall one-year survival was 75% (95%CI: 
70%-81%). In men it was 64% (52%-78%) and in 
women 82% (73%-84%). Figure 2 shows Kaplan-
Meier curves for statistically significant variables 
according to the log-rank test. After adjustment 
for age, the variables gender, ASA score, presence 
of comorbidities, and number of comorbidities 
remained as significant predictors of mortality 
(Table 2). No interaction between variable was 
identified.
Table 3 shows the results of the multivari-
ate Cox’s proportional hazards model. Accord-
ingly, male gender (HR = 2.54; 95%CI: 1.40-4.58), 
III/V ASA score (HR = 1.95; 95%CI: 1.10-3.47), age 
(HR = 1.06; 95%CI: 1.03-1.10), and delay to sur-
gery (HR = 1.07; 95%CI: 1.03-1.12) were indepen-
dent and statistically significant predictors of 
survival after PFF.
Discussion
Mortality after PFF creates a major clinical and 
public health burden. One-fourth of patients 
in our study had died after one year. Increased 
mortality was associated with increasing age, 
Figure 2
Kaplan-Meier curves with significant log-rank test for gender, daily activities before fracture, ASA score, heart disease, respiratory disease, dementia, anemia, 
and number of comorbidities. Cohort study of 252 patients admitted to the Orthopedic Ward of São João Hospital, Portugal (May 1st, 2008,  
to April 30th, 2009).
(continues)
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Figure 2 (continued)
longer delay to surgery, male gender, and worse 
ASA score.
Overall one-year mortality in men (34.6%) 
was higher than reported in some European 
countries such as Ireland (30.1%), Norway (31%), 
and the Netherlands (33%). Meanwhile, in wom-
en, one-year mortality (21.4%) was higher than in 
Ireland and Norway, but lower than in the Neth-
erlands 22,23,24. In Portugal, as far as we know only 
one other prospective cohort (patients > 65 years 
old) studied survival after PFF 17, and overall 
mortality in women was similar (22.2%), while 
in men our study showed lower overall mortality 
(48.3%). However, the results should be analyzed 
with caution, since this other study included pa-
tients more than 65 years of age.
Even after adjusting for age, ASA score, and 
delay to surgery, men showed 2.54 times high-
er mortality risk (95%CI: 1.40-4.58) in women. 
These results are similar to findings from a pro-
spective cohort of 218 patients in Spain (2007), 
with a relative risk of 2.44 (95%CI: 1.01-5.93) after 
adjusting for age, type of fracture, living situation, 
functional status prior to the fracture, mental sta-
tus, comorbidities, delirium during admission, 
and situation at discharge (patients discharged 
to the community versus to an institution) 25.
The gender differences in mortality are dif-
ficult to explain, although it appears that men 
with PFF tend to be more ill and frailer than 
women, making them more vulnerable to post-
operative complications 26. A recent study on 
cause of death in patients after PFF found that 
men were more likely to die from respiratory dis-
eases, malignant neoplasms, and cardiovascular 
diseases 27. In our study, although complications 
and causes of death were not studied, we identi-
fied a higher prevalence of respiratory diseases 
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in men, and more men were on antithrombotic 
medication prior to the fracture, placing them 
at greater risk of respiratory complications and 
thromboembolic events.
Age increased the risk of mortality after a 
PFF, with a 6% increase in mortality for each 
year (HR = 1.06; 95%CI: 1.03-1.10) in our study. 
A similar prospective cohort study in Italy with 
3,707 patients > 50 years of age found a similar 
risk (HR = 1.08; 95%CI: 1.06-1.09) 28.
A controversial factor affecting mortality af-
ter PFF is time between admission and surgery 
29,30,31. Although the optimal time for surgery af-
ter PFF in the elderly is not clear, most authors 
report that early surgical intervention (< 24, < 48, 
or < 72 hours) is associated with better prognosis 
and improved health status 15,31,32. Delay to sur-
gery prolongs hospital stay and increases the risk 
of pulmonary embolism, deep venous thrombo-
sis, heart failure, urinary infection, and pressure 
sores 33,34,35, thus delaying rehabilitation and in-
creasing the risk of death.
Table 2
Age-adjusted hazard ratios (HR) for one-year mortality after proximal femur fracture. Cohort study of 252 patients admitted to 
the Orthopedic Ward of São João Hospital, Portugal (May 1st, 2008, to April 30th, 2009).
Variable Crude 
HR (95%CI)
Age-adjusted 
HR (95%CI)
Gender
Female 1.00 1.00
Male 1.85 (1.06-3.21) 2.44 (1.38-4.31)
Daily activities before fracture (hours per day)
≥ 4 1.00 1.00
< 4 1.88 (1.02-3.48) 1.54 (0.82-2.90)
ASA score
ASA I-II 1.00 1.00
ASA III-IV 2.38 (1.36-4.17) 2.27 (1.29-3.98)
Comorbidities
Without heart disease 1.00 1.00
With heart disease 2.31 (1.39-3.86) 2.06 (1.23-3.44)
Without respiratory disease 1.00 1.00
With respiratory disease 2.03 (1.14-3.61) 2.11 (1.19-3.76)
Without dementia 1.00 1.00
With dementia 1.83 (1.03-3.25) 1.82 (1.02-3.22)
Without anemia 1.00 1.00
With anemia 1.91 (1.12-3.26) 1.72 (1.01-2.96)
Number of comorbidities
0-1 1.00 1.00
2-4 1.70 (0.73-3.95) 1.66 (0.71-3.84)
≥ 5 3.32 (1.45-7.60) 3.08 (1.34-7.06)
Delay to surgery 1.08 (1.03-1.12) 1.08 (1.03-1.12)
95%CI: 95% confidence interval.
Table 3
Final Cox’s proportional hazards analysis. Predictors of one-year survival after proximal femur  
fracture. Cohort study of 252 patients admitted to the Orthopedic Ward of São João 
Hospital, Portugal (May 1st, 2008, to April 30th, 2009).
Variable Crude 
HR (95%CI)
Adjusted * 
HR (95%CI)
Gender
Female 1.00 1.00
Male 1.85 (1.06-3.21) 2.54 (1.40-4.58)
ASA score
ASA I/II 1.00 1.00
ASA III/IV 2.38 (1.36-4.17) 1.95 (1.10-3.47)
Age 1.05 (1.02-1.08) 1.06 (1.03-1.10)
Delay to surgery 1.08 (1.03-1.12) 1.07 (1.03-1.12)
95%CI: 95% confidence interval; HR: hazard ratio. 
* HR adjusted for gender, age, delay to surgery, and ASA score.
Campos S et al.1536
Cad. Saúde Pública, Rio de Janeiro, 31(7):1528-1538, jul, 2015
In our study, each day of delay to surgery was 
associated with a 7% increase in risk of death. 
Time to surgery can help explain gender differ-
ences in survival. In our study, men were less 
likely than women to undergo surgery on the 
day of admission or on the following day. Sur-
gery is often postponed to stabilize patients’ 
clinical condition and optimize their hemody-
namic status, since most patients admitted after 
a PFF are clinically unstable, dehydrated, ane-
mic, and malnourished 36. In addition, patients 
on antithrombotic medication prior to the frac-
ture (highly common in the elderly for prevent-
ing thrombosis and atrial fibrillation) normally 
have their surgery delayed to prevent excessive 
intraoperative bleeding 37,38. However, accord-
ing to our findings a simple analysis of the use 
of antithrombotic medication does not appear 
to result in differences in time to surgery, since 
men on antithrombotic medication prior to sur-
gery waited an average of 0.5 days longer than 
women. On the other hand, when analyzing ASA 
score and time to surgery, only 7% of men with 
ASA III or IV underwent surgery on the day of ad-
mission or the following day, compared to 34% of 
women with the same ASA score. This indicates 
that even if there is no difference in ASA between 
men and women, the comorbidities that contrib-
ute to higher ASA scores in men require longer 
time for stabilization, thus resulting in longer 
time to surgery.
In our final Cox’s proportional hazards analy-
sis, ASA score, which takes severity of comorbidi-
ties into consideration, was found to be useful in 
predicting mortality in patients with a PFF, cor-
roborating other studies 10,39.
The study presents some limitations. Partici-
pants’ mental status was not tested objectively. 
However, we evaluated their orientation in time 
and space based on their answers on age, date 
and place of birth, and place of residence. Con-
trary to other studies 40,41, we did not find an as-
sociation between mortality and daily activities 
prior to hip fracture; however, this may have re-
sulted from limitations in the way the variable 
was collected, by categories: < 4 hours versus ≥ 
4 hours of daily activity, not taking into consid-
eration previous limitation in walking or use of 
walking aids.
The study’s strong points are related to the de-
sign, as a prospective cohort study conducted in 
the second largest hospital in Portugal. Data were 
collected directly from patients and from objec-
tive and standardized records, thereby increasing 
data quality. In addition, unlike other studies, the 
same interviewer applied all the questionnaires 
at baseline and follow-up, also enhancing data 
quality. Finally, diagnosis and treatment of PFF 
were confirmed by consulting imaging records, 
thereby avoiding misclassification of fractures, 
while type of surgery and comorbidities were as-
sessed from patients’ clinical charts, thus avoid-
ing recall bias.
In conclusion, in the present study, increased 
risk of death after PFF was associated with in-
creasing age, delay to surgery, male gender, and 
worse ASA score. Patients with PFF require a mul-
tidisciplinary approach and the use of clinical 
score systems (e.g., ASA score) together with data 
that can be easily and routinely collected from 
patients’ charts (time to surgery, medications), 
thus facilitating early identification of high-risk 
patients and treatment adjustments. The high 
mortality rates identified in this setting also call 
for improvements in post-fracture treatment and 
care in Portugal.
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Resumen
Los objetivos del estudio fueron analizar la superviven-
cia tras un año y los factores asociados para enfermos 
con fractura de la cadera (bajo impacto). Fue constitui-
da una cohorte con todos los enfermos hospitalizados 
en el servicio de ortopedia del segundo mayor hospital 
de Portugal (mayo/2008 – abril/2009). La supervivencia 
fue evaluada a los 3, 6, 9 y 12 meses tras la fractura y re-
lacionada con factores demográficos, estilo de vida, his-
toria clínica y factores médicos (tipo de fractura, fecha 
de la cirugía, tratamiento y riesgo preoperatorio). De 
los 340 enfermos hospitalizados, 252 (78,9% mujeres) 
fueron incluidos. La mortalidad a los 3, 6, 8 y 12 meses 
de seguimiento fue de un 21,2%, 20%, 28,8%, 34,6% en 
hombres y un 7,8%, 13,5%, 19,2%, 21,4% en mujeres. Los 
factores asociados con la mortalidad fueron: sexo mas-
culino (HR = 2,54; IC95%: 1,40-4,58), ASA puntuación 
más elevada, III/IV vs. I/II (HR = 1,95; IC95%: 1,10-3,47), 
edad (HR = 1,06; IC95%: 1,03-1,10) y días de retraso en 
la cirugía (HR = 1,07; IC95%: 1,03-1,12). Los factores es-
tán en su mayoría relacionados con las características 
del enfermo en la admisión.
Fracturas de Cadera; Supervivencia; Mortalidad
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